Alto Neuroscience, Inc. (ANRO)
15.13
+0.45
(+3.07%)
USD |
NYSE |
Dec 12, 16:00
15.14
+0.01
(+0.07%)
After-Hours: 20:00
Alto Neuroscience Total Assets (Quarterly): 147.01M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.14B |
| Eli Lilly & Co. | 114.94B |
| Pfizer Inc. | 208.73B |
| Brainstorm Cell Therapeutics, Inc. | 1.38M |
| CEL-SCI Corp. | 20.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 35.45M |
| Shareholders Equity (Quarterly) | 111.56M |
| Debt to Equity Ratio | 0.2467 |
| Current Ratio | 15.42 |
| Net Debt Paydown Yield | -3.20% |